★ Sign in to follow
SN

Stefan Nilsson

SE·Finansinspektionen
Lipigon Phartmaceuticals AB
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
22
Company
1
▲ Purchases (15 ops.)
€90k
▼ Sales (0 ops.)
—

Latest filing published 06 Dec 2024 for Lipigon Phartmaceuticals AB, €5,005.

Filing timeline

BuySale
Stefan Nilsson

Insider track record

Disclosed buys
15
Disclosed sells
0
Signal history

Closed purchases

Market purchases
15

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Stefan Nilsson: trading record in brief

Stefan Nilsson appears in our data through filings on Lipigon Phartmaceuticals AB shares, published by Finansinspektionen. Between 28 March 2022 and 3 December 2024, the trades on record add up to 22 filings.

No open-market sale appears; the market trades are 15 purchases worth €90k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2024: 6 purchases and no sales on the market.

A typical purchase (the median) is worth €5,005. Of 14 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 6 December 2024 with an open-market purchase (€5,005) in Lipigon Phartmaceuticals AB. Typically, a trade is published a median of 2 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Stefan Nilsson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    57,733 SEK22FI-SE
    342,315 shares@ SEK 0.16870.0% of flowAktieISIN SE0015382072FI:csv-bfd9e64a453634156c67
    Canonical exit: 2 Mar 2025 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    18,500 SEK22FI-SE
    95,164 shares@ SEK 0.19440.0% of flowAktieISIN SE0015382072FI:csv-7c2add942327a53cbdad
    Canonical exit: 3 Mar 2025 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    75,104 SEK22FI-SE
    313,425 shares@ SEK 0.23960.0% of flowAktieISIN SE0015382072FI:csv-995d252b0647b5b89f78
    Canonical exit: 9 Dec 2024 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    38,950 SEK22FI-SE
    136,056 shares@ SEK 0.28630.0% of flowAktieISIN SE0015382072FI:csv-8f72369ede9d63ed0328
    Canonical exit: 15 Sept 2024 (T+90)
  • ●
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    10,500 SEK22FI-SE
    52,500 shares@ SEK 0.200.0% of flowAktieISIN SE0015382072FI:csv-da64d890a74ea290e601
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    47,443 SEK0FI-SE
    790,715 shares@ SEK 0.060.0% of flowTeckningsoptionFI:csv-ad8bbbefe085b0b2e21d
    Canonical exit: 25 Jul 2024 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    101,293 SEK34FI-SE
    300,852 shares@ SEK 0.33670.0% of flowAktieISIN SE0015382072FI:csv-0d03c7ca7c71fece3124
    Canonical exit: 18 Jul 2024 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    134,771 SEK22FI-SE
    311,804 shares@ SEK 0.43220.0% of flowAktieISIN SE0015382072FI:csv-eb263b6244c8a61739bb
    Canonical exit: 19 Mar 2024 (T+90)
  • ●
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    3,150 SEK0FI-SE
    10,500 shares@ SEK 0.300.0% of flowTeckningsoptionISIN SE0019914094FI:csv-e89885b22859033365ea
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    67,865 SEK22FI-SE
    182,432 shares@ SEK 0.3720.0% of flowAktieISIN SE0015382072FI:csv-2789082dbcff97802885
    Canonical exit: 18 Oct 2023 (T+90)
  • ●
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    61,250 SEK0FI-SE
    17,500 shares@ SEK 3.500.0% of flowTeckningsrätt/UniträttISIN SE0019914110FI:csv-a309dad28b11ff5e3daa
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    44,499 SEK22FI-SE
    40,825 shares@ SEK 1.090.0% of flowAktieISIN SE0015382072FI:csv-b2878e34a5417dfb2232
    Canonical exit: 20 Apr 2023 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    44,500 SEK22FI-SE
    37,083 shares@ SEK 1.203.7% of flowAktieISIN SE0015382072FI:csv-6c7b1154cfd964220f66
    Canonical exit: 23 Feb 2023 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    67,977 SEK22FI-SE
    35,590 shares@ SEK 1.910.0% of flowAktieISIN SE0015382072FI:csv-86791a333dbe864abe18
    Canonical exit: 29 Nov 2022 (T+90)
  • ●
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    161,250 SEK0FI-SE
    75,000 shares@ SEK 2.1534.6% of flowBTA (betald tecknad aktie)ISIN SE0017911613FI:csv-88296dd538bd447edc63
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    114,937 SEK22FI-SE
    32,016 shares@ SEK 3.590.0% of flowAktieISIN SE0015382072FI:csv-2b5df65c355366fbbf55
    Canonical exit: 2 Aug 2022 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    20,398 SEK22FI-SE
    6,688 shares@ SEK 3.050.0% of flowAktieISIN SE0015382072FI:csv-db567022b040b46ef830
    Canonical exit: 2 Aug 2022 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    138,516 SEK22FI-SE
    42,752 shares@ SEK 3.240.0% of flowAktieISIN SE0015382072FI:csv-50379515bf3b0eae9aa4
    Canonical exit: 4 Aug 2022 (T+90)
  • ▲
    Stefan Nilsson
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    22,273 SEK22FI-SE
    4,863 shares@ SEK 4.580.0% of flowAktieISIN SE0015382072FI:csv-12e9d5ab60e77a32387b
    Canonical exit: 26 Jun 2022 (T+90)

19 of 19 declarations

Related entities

No related entities found.